Search Results - Andrew Cherniack
- Showing 1 - 2 results of 2
-
1
67 Cancer aneuploidy is associated with a distinct tumor immune microenvironment and impacts outcomes to immune checkpoint inhibition in nonsquamous non-small cell lung cancer by Mark Awad, Gonzalo Recondo, Giuseppe Lamberti, Scott Rodig, Joao Victor Alessi, Victor Vaz, Adriana Barrichello, Yvonne Lin-Liu, Hersh Gupta, Xinan Wang, Andrew Cherniack, Kristen Felt
Published in Journal for ImmunoTherapy of Cancer (2021-11-01)Article -
2
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models by Samuel Y. Ng, Noriaki Yoshida, Amanda L. Christie, Mahmoud Ghandi, Neekesh V. Dharia, Joshua Dempster, Mark Murakami, Kay Shigemori, Sara N. Morrow, Alexandria Van Scoyk, Nicolas A. Cordero, Kristen E. Stevenson, Maneka Puligandla, Brian Haas, Christopher Lo, Robin Meyers, Galen Gao, Andrew Cherniack, Abner Louissaint, Valentina Nardi, Aaron R. Thorner, Henry Long, Xintao Qiu, Elizabeth A. Morgan, David M. Dorfman, Danilo Fiore, Julie Jang, Alan L. Epstein, Ahmet Dogan, Yanming Zhang, Steven M. Horwitz, Eric D. Jacobsen, Solimar Santiago, Jian-Guo Ren, Vincent Guerlavais, D. Allen Annis, Manuel Aivado, Mansoor N. Saleh, Amitkumar Mehta, Aviad Tsherniak, David Root, Francisca Vazquez, William C. Hahn, Giorgio Inghirami, Jon C. Aster, David M. Weinstock, Raphael Koch
Published in Nature Communications (2018-05-01)Get full text
Article
